4//SEC Filing
Leyman Barbara 4
Accession 0001415889-24-019462
CIK 0001382101other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:11 PM ET
Size
8.1 KB
Accession
0001415889-24-019462
Insider Transaction Report
Form 4
Leyman Barbara
Chief Business Officer
Transactions
- Award
Restricted Stock Units (RSUs)
2024-07-08+100,000→ 100,000 totalExp: 2028-07-08→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy Common Stock)
2024-07-08+125,000→ 125,000 totalExercise: $3.04Exp: 2034-07-08→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]The option vests as to 25% of the total award on July 8, 2025, then in equal monthly installments over the following three years, subject to the reporting person's continued service to the issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on July 8, 2025, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0002028309
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:11 PM ET
- Size
- 8.1 KB